Evidence map›Paper›PMID 31411676›Full record

ArticleHuman molecular genetics2019

Spp1 (osteopontin) promotes TGFβ processing in fibroblasts of dystrophin-deficient muscles through matrix metalloproteinases.

Irina Kramerova, Chino Kumagai-Cresse, Natalia Ermolova, Ekaterina Mokhonova, Masha Marinov, Joana Capote, Diana Becerra, Mattia Quattrocelli, Rachelle H Crosbie, Ellen Welch and 2 more

Open access · greenAbstract read
In one paragraph

Article in Human molecular genetics, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 73 papers.

0numbers the graph read from it
0cells of the map it votes in
73citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

73 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Collagen-producing eye cell atlas reveals distinct fibroblast fates in early injury vs. fibrotic subretinal disease.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. The Landscape of SPP1Immunology · 2025
    Review
  19. Review
  20. The functional role of the extracellular matrix in inflammatory bowel disease associated gut fibrosis.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review

13 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 1 country.

Irina KramerovaDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Chino Kumagai-CresseDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Natalia ErmolovaDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Ekaterina MokhonovaDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Masha MarinovDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Joana CapoteDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Diana BecerraDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Mattia QuattrocelliCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine.
Rachelle H CrosbieDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
Ellen WelchPTC Therapeutics.
Elizabeth M McNallyCenter for Genetic Medicine, Northwestern University Feinberg School of Medicine.
Melissa J SpencerDepartment of Neurology, David Geffen School of Medicine, University of California, Los Angeles.
University of California, Los Angeles · USMuscular Dystrophy Association · USNorthwestern University · USPTC Therapeutics (United States) · US

Funding

Training and education CoreU54AR052646 · NIAMS · UNIVERSITY OF PENNSYLVANIA · PI MCNALLY, ELIZABETH M, SWEENEY, H LEE · 2005 to 2020
$24.1M
Structure-Function Analysis of SarcospanR01AR048179 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI CROSBIE, RACHELLE HOPE · 2001 to 2023
$6.9M
UCLA Muscular Dystrophy Core CenterP30AR057230 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MICELI, M CARRIE · 2009 to 2018
$6.2M
Muscle Cell Biology, Pathophysiology, and TherapeuticsT32AR065972 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Rachelle Hope Crosbie, THOMAS A. RANDO · 2016 to 2026
$3.9M
THERAPEUTIC APPROACHES FOR MUSCULAR DYSTROPHYR01AR046911 · NIAMS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI SPENCER, MELISSA JAN · 2000 to 2006
$2.3M
Regulating fibrosis and growth through latent TGFbeta binding proteinsR01HL140938 · NHLBI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI MCNALLY, ELIZABETH M · 2018 to 2021
$1.6M
Glucocorticoid and circadian clock coregulation of insulin sensitivity and metabolismK01DK121875 · NIDDK · NORTHWESTERN UNIVERSITY AT CHICAGO · PI QUATTROCELLI, MATTIA · 2019 to 2021
$444k
NHLBI NIH HHS R01 HL140938NIAMS NIH HHS P30 AR057230NIAMS NIH HHS R01 AR046911NIAMS NIH HHS R01 AR048179NIAMS NIH HHS T32 AR065972NIAMS NIH HHS U54 AR052646NIDDK NIH HHS K01 DK121875
6 · The paper itself

Abstract

Duchenne muscular dystrophy (DMD) is caused by mutations in the gene encoding dystrophin. Prior work has shown that DMD progression can vary, depending on the genetic makeup of the patient. Several modifier alleles have been identified including LTBP4 and SPP1. We previously showed that Spp1 exacerbates the DMD phenotype in the mdx mouse model by promoting fibrosis and by skewing macrophage polarization. Here, we studied the mechanisms involved in Spp1's promotion of fibrosis by using both isolated fibroblasts and genetically modified mice. We found that Spp1 upregulates collagen expression in mdx fibroblasts by enhancing TGFβ signaling. Spp1's effects on TGFβ signaling are through induction of MMP9 expression. MMP9 is a protease that can release active TGFβ ligand from its latent complex. In support for activation of this pathway in our model, we showed that treatment of mdx fibroblasts with MMP9 inhibitor led to accumulation of the TGFβ latent complex, decreased levels of active TGFβ and reduced collagen expression. Correspondingly, we found reduced active TGFβ in Spp1-/-mdxB10 and Mmp9-/-mdxB10 muscles in vivo. Taken together with previous observations of reduced fibrosis in both models, these data suggest that Spp1 acts upstream of TGFβ to promote fibrosis in mdx muscles. We found that in the context of constitutively upregulated TGFβ signaling (such as in the mdxD2 model), ablation of Spp1 has very little effect on fibrosis. Finally, we performed proof-of-concept studies showing that postnatal pharmacological inhibition of Spp1 reduces fibrosis and improves muscle function in mdx mice.

Indexed as

AnimalsCollagen Type IDisease Models, AnimalDystrophinExtracellular MatrixFemaleFibroblastsFibrosisMaleMatrix Metalloproteinase 9MiceMice, Inbred mdxMice, KnockoutMuscle, SkeletalMuscular Dystrophy, DuchenneOsteopontinCollagen Type IDystrophinMatrix Metalloproteinase 9Mmp9 protein, mouseOsteopontinSpp1 protein, mouseTransforming Growth Factor beta

Identifiers

PMID31411676
PMCPMC7345878
OpenAlexW2967248220

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.